BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Sep 27, 2010
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Neptune Technologies preclinical data

In healthy rats, human equivalent dosing with 1 g/day of Acasti Pharma Inc.'s CaPre long-chain omega-3 phospholipids for 2 months increased total levels of the cardioprotective omega-3 fatty...

Read the full 116 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >